Sieve-Smith L - Search Results

1

Secondhand smoke, hypofibrinolysis, and Legg-Perthes disease.

Glueck CJ, Freiberg RA, Crawford A, Gruppo R, Roy D, Tracy T, Sieve-Smith L, Wang P. Glueck CJ, et al. Clin Orthop Relat Res. 1998 Jul;(352):159-67. Clin Orthop Relat Res. 1998. PMID: 9678044

2

The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis.

Glueck CJ, Fontaine RN, Gruppo R, Stroop D, Sieve-Smith L, Tracy T, Wang P. Glueck CJ, et al. Clin Orthop Relat Res. 1999 Sep;(366):133-46. doi: 10.1097/00003086-199909000-00017. Clin Orthop Relat Res. 1999. PMID: 10627727

3

Anticoagulant therapy for osteonecrosis associated with heritable hypofibrinolysis and thrombophilia.

Glueck CJ, Freiberg RA, Fontaine RN, Sieve-Smith L, Wang P. Glueck CJ, et al. Among authors: sieve smith l. Expert Opin Investig Drugs. 2001 Jul;10(7):1309-16. doi: 10.1517/13543784.10.7.1309. Expert Opin Investig Drugs. 2001. PMID: 11772253 Review.

4

Estrogen replacement therapy, thrombophilia, and atherothrombosis.

Glueck CJ, Wang P, Fontaine RN, Sieve-Smith L, Lang JE. Glueck CJ, et al. Among authors: sieve smith l. Metabolism. 2002 Jun;51(6):724-32. doi: 10.1053/meta.2002.32729. Metabolism. 2002. PMID: 12037725

5

Whether, to what degree, and why lipoprotein(a) levels change over time.

Glueck CJ, Tracy T, Sieve-Smith L, Wang P. Glueck CJ, et al. Clin Chim Acta. 1995 Jun 30;238(1):11-9. doi: 10.1016/0009-8981(95)06070-t. Clin Chim Acta. 1995. PMID: 7554292 Clinical Trial.

6

A preliminary pilot study of treatment of thrombophilia and hypofibrinolysis and amelioration of the pain of osteonecrosis of the jaws.

Glueck CJ, McMahon RE, Bouquot JE, Tracy T, Sieve-Smith L, Wang P. Glueck CJ, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Jan;85(1):64-73. doi: 10.1016/s1079-2104(98)90400-0. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998. PMID: 9474617 Clinical Trial.

7

Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.

Glueck CJ, Wang P, Fontaine R, Tracy T, Sieve-Smith L. Glueck CJ, et al. Metabolism. 1999 Apr;48(4):511-9. doi: 10.1016/s0026-0495(99)90113-0. Metabolism. 1999. PMID: 10206447 Clinical Trial.

8

Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular disease.

Glueck CJ, Lang JE, Tracy T, Sieve-Smith L, Wang P. Glueck CJ, et al. Am J Cardiol. 1999 May 15;83(10):1490-4, A8. doi: 10.1016/s0002-9149(99)00130-7. Am J Cardiol. 1999. PMID: 10335769

9

Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the factor V Leiden mutation (resistance to activated protein C).

Glueck CJ, Wang P, Fontaine RN, Tracy T, Sieve-Smith L, Lang JE. Glueck CJ, et al. Am J Cardiol. 1999 Sep 1;84(5):549-54. doi: 10.1016/s0002-9149(99)00375-6. Am J Cardiol. 1999. PMID: 10482153

10

Contribution of fasting hyperinsulinemia to prediction of atherosclerotic cardiovascular disease status in 293 hyperlipidemic patients.

Glueck CJ, Lang JE, Tracy T, Sieve-Smith L, Wang P. Glueck CJ, et al. Metabolism. 1999 Nov;48(11):1437-44. doi: 10.1016/s0026-0495(99)90156-7. Metabolism. 1999. PMID: 10582554

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters